Cell-specific, promoter-dependent mineralocorticoid agonist activity of spironolactone

被引:35
作者
Massaad, C
Lombes, M
Aggerbeck, M
RafestinOblin, ME
Barouki, R
机构
[1] HOP HENRI MONDOR,INSERM,U99,F-94010 CRETEIL,FRANCE
[2] FAC XAVIER BICHAT,INSERM U246,F-75018 PARIS,FRANCE
关键词
D O I
10.1124/mol.51.2.285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The agonist activity of the antimineralocorticoid spironolactone was evaluated in various cell lines through the use of transfection experiments. The target promoters were derived from the Delta MTV promoter in which one or several glucocorticoid-responsive elements (GRE) were inserted in tandem. Spironolactone at 100 nM activated by 6-fold the GRE/Delta MTV promoter in the human hepatoma HepG2 cell line and only partially prevented the 10-fold activation of this promoter by 0.1 nM aldosterone. Both effects were completely dependent on the cotransfection of an expression vector for the mineralocorticoid receptor. The half-maximal agonist effect of spironolactone was similar to its half-maximal antagonist effect (similar to 10 nM). For the GRE-2/Delta MTV, GRE-4/Delta MTV, and wild-type MMTV promoters, the activation by aldosterone was much more potent (70-, 100-, and 110-fold, respectively), whereas spironolactone elicited a 10-, 24-, and 25-fold activation, respectively. Thus, the effect of both compounds and the relative efficiency of spironolactone, compared with that of aldosterone, were dependent on the number of GREs present in the regulatory region of the promoter. The agonist effect of spironolactone was cell specific. Indeed, although spironolactone agonist activity was observed in H5 kidney tubule cells, none could be detected at concentrations of less than or equal to 1 mu M in the CV1 monkey fibroblast cells. In contrast, the antagonist effect was observed in all cells. Furthermore, other antimineralocorticoids, such as RU 26752 and progesterone, also displayed mineralocorticoid receptor-dependent agonist activity in the HepG2 cells. The antiprogesterone RU 486 and the antiandrogen cyproterone acetate were ineffective at less than or equal to 1 mu M In conclusion, we show that under certain experimental conditions, several antimineralocorticoids display significant agonist activity in a cell-specific and promoter-dependent manner.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 40 条
  • [1] REGULATION OF THE CYTOSOLIC ASPARTATE-AMINOTRANSFERASE HOUSEKEEPING GENE PROMOTER BY GLUCOCORTICOIDS, CAMP, AND INSULIN
    AGGERBECK, M
    GARLATTI, M
    FEILLEUXDUCHE, S
    VEYSSIER, C
    DAHESHIA, M
    HANOUNE, J
    BAROUKI, R
    [J]. BIOCHEMISTRY, 1993, 32 (35) : 9065 - 9072
  • [2] COOPERATIVE BINDING OF ESTROGEN-RECEPTOR TO DNA DEPENDS ON SPACING OF BINDING-SITES, FLANKING SEQUENCE, AND LIGAND
    ANOLIK, JH
    KLINGE, CM
    HILF, R
    BAMBARA, RA
    [J]. BIOCHEMISTRY, 1995, 34 (08) : 2511 - 2520
  • [3] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [4] THE ANTISTEROID RU486 - ITS CELLULAR AND MOLECULAR-MODE OF ACTION
    BAULIEU, EE
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1991, 2 (06) : 233 - 239
  • [5] THE PROGESTERONE ANTAGONIST RU486 ACQUIRES AGONIST ACTIVITY UPON STIMULATION OF CAMP SIGNALING PATHWAYS
    BECK, CA
    WEIGEL, NL
    MOYER, ML
    NORDEEN, SK
    EDWARDS, DP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4441 - 4445
  • [6] CHARACTERIZATION OF HUMAN MINERALOCORTICOSTEROID RECEPTOR EXPRESSED IN THE BACULOVIRUS SYSTEM
    BINART, N
    LOMBES, M
    RAFESTINOBLIN, ME
    BAULIEU, EE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10681 - 10685
  • [7] AUTORADIOGRAPHIC EVIDENCE OF NUCLEAR-BINDING OF SPIRONOLACTONE IN RABBIT CORTICAL COLLECTING TUBULE
    BONVALET, JP
    BLOTCHABAUD, M
    FARMAN, N
    WANSTOK, F
    [J]. ENDOCRINOLOGY, 1991, 128 (01) : 280 - 284
  • [8] MECHANISM OF THE ANTI-MINERALOCORTICOID EFFECTS OF SPIROLACTONES
    CORVOL, P
    CLAIRE, M
    OBLIN, ME
    GEERING, K
    ROSSIER, B
    [J]. KIDNEY INTERNATIONAL, 1981, 20 (01) : 1 - 6
  • [9] ALDOSTERONE ANTAGONISTS DESTABILIZE THE MINERALOCORTICOSTEROID RECEPTOR
    COUETTE, B
    LOMBES, M
    BAULIEU, EE
    RAFESTINOBLIN, ME
    [J]. BIOCHEMICAL JOURNAL, 1992, 282 : 697 - 702
  • [10] Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure
    Couette, B
    Fagart, J
    Jalaguier, S
    Lombes, M
    Souque, A
    RafestinOblin, ME
    [J]. BIOCHEMICAL JOURNAL, 1996, 315 : 421 - 427